PRJNA379755
Effect of long-term erythromycin on the pharyngeal microbiota composition and antibiotic resistance gene carriage: analysis from the randomised, double-blind, placebo-controlled trial
The study investigates the pharyngeal microbiota composition and antibiotic resistance gene carriage of non-cystic fibrosis bronchiectasis patients receiving erythromycin for a total of 48 weeks.